Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03481114 · ClinicalTrials.gov registry record · Phase 2
Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer
A Phase 2 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 55
- Enrollment target
NCT03481114 is a Phase 2 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 55 participants.
The verdict
NCT03481114, a Phase 2 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 55 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate patient-reported outcomes during and after concurrent chemoradiotherapy for locally-advanced non-small cell lung cancer. Patients will be randomized to a standard 6-week radiotherapy course or a 4-week radiotherapy course using dose-painting based on pre-treatment Positron Emission Tomography (PET) findings.
Interventions
- COMBINATION_PRODUCT PET-based, dose-painted, accelerated chemoradiotherapy
- COMBINATION_PRODUCT Standard chemoradiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2017-08-28 |
| Est. Completion | 2023-12-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03481114
The ClinicalTrials.gov registry entry for NCT03481114 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PET-based, dose-painted, accelerated chemoradiotherapy is the first listed.
NCT03481114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03481114 about?
NCT03481114 is a clinical study titled "Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer". The primary objective of this study is to evaluate patient-reported outcomes during and after concurrent chemoradiotherapy for locally-advanced non-small cell lung cancer. Patients will be randomized to a standard 6-week radiotherapy course or a 4-week radiotherapy course using dose-painting based o...
What is the current status of trial NCT03481114?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 55 participants. The study started on 2017-08-28. Estimated completion is 2023-12-27.
What interventions are being tested in trial NCT03481114?
The interventions under investigation include: PET-based, dose-painted, accelerated chemoradiotherapy (COMBINATION_PRODUCT), Standard chemoradiotherapy (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03481114?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.